Profilaktika sosudistykh oslozhneniy sakharnogo diabeta: reshennye i nereshennye voprosy
- Authors: Shestakova M.V1, Yarek-Martynov I.R1, Koshel' L.A1
-
Affiliations:
- ГУ Эндокринологический научный центр РАМН
- Issue: Vol 4, No 10 (2002)
- Pages: 527-531
- Section: Articles
- URL: https://bakhtiniada.ru/2075-1753/article/view/91529
- ID: 91529
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
M. V Shestakova
ГУ Эндокринологический научный центр РАМНМосква
I. R Yarek-Martynov
ГУ Эндокринологический научный центр РАМНМосква
L. A Koshel'
ГУ Эндокринологический научный центр РАМНМосква
References
- Kramer W. Exp Clin Endocrinol Diabetes 1999; 107 (Suppl. 2): S52-S61.
- Stalmer J, Vaccaro O, Neaton J.D, Wentworth D. Diabetes Care 1993; 16: 1414-31.
- European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabetic Med. 16. 1999.
- Stratton I, Adler A, Neil H. et al. BMJ 2000; 321: 405-12.
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood - glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
- Adler A, Stratton I.M, Neil H. et al. BMJ 2000; 321: 412-9.
- UK Prospective Diabetes Study Group (UKPDS). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13.
- Hansson L, Zanchetti A, Carruthers S.G. et al. Lancet 1998; 351: 1755-62.
- Sowers J.R, Epsrein M, Frohlich E.D. Hypertension 2001; 37: 1053-9.
- Pyurala K. Diabetes care 1997; 20: 614-20.
- ADVANCE Management Committee. Study Rationale and design of ADVANCE: Action in Diabetes and Vascular disease - preterax and diamicron MR controlled evaluation. Diabetologia 2001; 44: 1118-20.
- Drouin P. J Diab Comps 2000; 14: 185-91.
Supplementary files
